Thromb Haemost 1981; 46(03): 581-583
DOI: 10.1055/s-0038-1653422
Original Article
Schattauer GmbH Stuttgart

The In Vitro Inhibitory Effect on Thrombin by 2,3-Diphosphoglycerate

D Del Principe
The Coagulation Laboratory, 1st Dept. of Pediatrics, Medical School, University of Rome, Italy
,
P M Strappini
The Coagulation Laboratory, 1st Dept. of Pediatrics, Medical School, University of Rome, Italy
,
S Del Vecchio
The Coagulation Laboratory, 1st Dept. of Pediatrics, Medical School, University of Rome, Italy
,
A Menichelli
The Coagulation Laboratory, 1st Dept. of Pediatrics, Medical School, University of Rome, Italy
,
G Biancini
The Coagulation Laboratory, 1st Dept. of Pediatrics, Medical School, University of Rome, Italy
,
E V Cosmi
*   The Departments of Anesthesiology and Obstetrics and Gynecology, Medical School, University of Rome, Italy
,
V Bastianon
The Coagulation Laboratory, 1st Dept. of Pediatrics, Medical School, University of Rome, Italy
,
C D’Arcangelo
The Coagulation Laboratory, 1st Dept. of Pediatrics, Medical School, University of Rome, Italy
› Institutsangaben
Weitere Informationen

Publikationsverlauf

Received 17. September 1980

Accepted 15. Juni 1981

Publikationsdatum:
05. Juli 2018 (online)

Preview

Summary

Thrombin, incubated with 2,3-diphosphoglycerate (150 nmol 2,3-DPG/1 NIH thrombin unit) lost up to 70% of its clotting activity, whereas the esterase activity remained unchanged. No fibrinopeptide release by thrombin was observed in the presence of 2,3-DPG. The fibrin polymerization was normal. By chromatography on Amberlite IRC-50, α-thrombin was eluted at pH 8.0. In presence of 2,3-DPG, α-thrombin was not eluted. Likely, 2,3-DPG can interfere with thrombin.